 REDWOOD CITY, Calif., May 17, 2022 GLOBE NEWSWIRE -- Soleno Therapeutics, Inc. Soleno NASDAQ: SLNO, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held May 23-26, 2022, virtually and in Miami, FL. 